Kau, T. R., Way, J. C. & Silver, P. A. Nuclear transport and cancer: from mechanism to intervention. Nat. Rev. Cancer 4, 106â117 (2004).
Suk, T. R. & Rousseaux, M. W. C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 15, 45 (2020).
Hung, M.-C. & Link, W. Protein localization in disease and therapy. J. Cell Sci. 124, 3381â3392 (2011).
Krauss, R., Bosanac, T., Devraj, R., Engber, T. & Hughes, R. O. Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration. Trends Pharmacol. Sci. 41, 281â293 (2020).
Thul, P. J. et al. A subcellular map of the human proteome. Science 356, eaal3321 (2017).
Wang, X. & Li, S. Protein mislocalization: mechanisms, functions and clinical applications in cancer. Biochim. Biophys. Acta 1846, 13â25 (2014).
Hill, R., Cautain, B., de Pedro, N. & Link, W. Targeting nucleocytoplasmic transport in cancer therapy. Oncotarget 5, 11â28 (2013).
Pasha, T. et al. Karyopherin abnormalities in neurodegenerative proteinopathies. Brain 144, 2915â2932 (2021).
Yu, Y. et al. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity. Hum. Mol. Genet. 28, 3486â3497 (2019).
Chou, C.-C. et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 21, 228â239 (2018).
Birsa, N., Bentham, M. P. & Fratta, P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin. Cell Dev. Biol. 99, 193â201 (2020).
Vance, C. et al. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 22, 2676â2688 (2013).
Wang, A. Y. & Liu, H. The past, present, and future of CRM1/XPO1 inhibitors. Stem Cell Investig. 6, 6 (2019).
Jans, D. A., Martin, A. J. & Wagstaff, K. M. Inhibitors of nuclear transport. Curr. Opin. Cell Biol. 58, 50â60 (2019).
Syed, Y. Y. Selinexor: first global approval. Drugs 79, 1485â1494 (2019).
Abdul Razak, A. R. et al. First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors. J. Clin. Oncol. 34, 4142â4150 (2016).
Griffith, M. et al. DGIdb: mining the druggable genome. Nat. Methods 10, 1209â1210 (2013).
Cromm, P. M. & Crews, C. M. Targeted protein degradation: from chemical biology to drug discovery. Cell Chem. Biol. 24, 1181â1190 (2017).
Burslem, G. M. & Crews, C. M. Small-molecule modulation of protein homeostasis. Chem. Rev. 117, 11269â11301 (2017).
Kanwal, C., Mu, S., Kern, S. E. & Lim, C. S. Bidirectional on/off switch for controlled targeting of proteins to subcellular compartments. J. Control. Release 98, 379â393 (2004).
Dixon, A. S., Constance, J. E., Tanaka, T., Rabbitts, T. H. & Lim, C. S. Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs. Pharm. Res. 29, 1098â1109 (2012).
Niopek, D. et al. Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells. Nat. Commun. 5, 4404 (2014).
Yumerefendi, H. et al. Light-induced nuclear export reveals rapid dynamics of epigenetic modifications. Nat. Chem. Biol. 12, 399â401 (2016).
Jayanthi, B., Bachhav, B., Wan, Z., Martinez Legaspi, S. & Segatori, L. A platform for post-translational spatiotemporal control of cellular proteins. Synth. Biol. (Oxf.) 6, ysab002 (2021).
Klemm, J. D., Beals, C. R. & Crabtree, G. R. Rapid targeting of nuclear proteins to the cytoplasm. Curr. Biol. 7, 638â644 (1997).
Geda, P. et al. A small molecule-directed approach to control protein localization and function. Yeast 25, 577â594 (2008).
Raschbichler, V., Lieber, D. & Bailer, S. M. NEX-TRAP, a novel method for in vivo analysis of nuclear export of proteins. Traffic 13, 1326â1334 (2012).
Robinson, M. S., Sahlender, D. A. & Foster, S. D. Rapid inactivation of proteins by rapamycin-induced rerouting to mitochondria. Dev. Cell 18, 324â331 (2010).
Ishida, M. et al. Synthetic self-localizing ligands that control the spatial location of proteins in living cells. J. Am. Chem. Soc. 135, 12684â12689 (2013).
Nakamura, A. et al. Chemogenetic control of protein anchoring to endomembranes in living cells with lipid-tethered small molecules. Biochemistry 59, 205â211 (2020).
Wing, C. E., Fung, H. Y. J. & Chook, Y. M. Karyopherin-mediated nucleocytoplasmic transport. Nat. Rev. Mol. Cell Biol. 23, 307â328 (2022).
Love, D. C., Sweitzer, T. D. & Hanover, J. A. Reconstitution of HIV-1 Rev nuclear export: independent requirements for nuclear import and export. Proc. Natl Acad. Sci. USA 95, 10608â10613 (1998).
Gibson, T. J., Seiler, M. & Veitia, R. A. The transience of transient overexpression. Nat. Methods 10, 715â721 (2013).
Gourisankar, S. et al. Rewiring cancer drivers to activate apoptosis. Nature 620, 417â425 (2023).
Højfeldt, J. W. et al. Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor. Mol. Endocrinol. 28, 249â259 (2014).
Gallagher, S. S., Miller, L. W. & Cornish, V. W. An orthogonal dexamethasoneâtrimethoprim yeast three-hybrid system. Anal. Biochem. 363, 160â162 (2007).
Gazorpak, M. et al. Harnessing PROTAC technology to combat stress hormone receptor activation. Nat. Commun. 14, 8177 (2023).
Pathak, R. et al. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors. Acta Neuropathol. 142, 361â374 (2021).
de Boer, E. M. J. et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 92, 86â95 (2020).
Dormann, D. et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841â2857 (2010).
Waibel, S., Neumann, M., Rabe, M., Meyer, T. & Ludolph, A. C. Novel missense and truncating mutations in FUS/TLS in familial ALS. Neurology 75, 815â817 (2010).
Bosco, D. A. et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 19, 4160â4175 (2010).
Cho, N. H. et al. OpenCell: endogenous tagging for the cartography of human cellular organization. Science 375, eabi6983 (2022).
Dong, H. et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat. Cancer 5, 601â624 (2024).
Coleman, M. P. & Freeman, M. R. Wallerian degeneration, WldS, and Nmnat. Annu. Rev. Neurosci. 33, 245â267 (2010).
Conforti, L. et al. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J. Cell Biol. 184, 491â500 (2009).
Babetto, E. et al. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J. Neurosci. 30, 13291â13304 (2010).
Fischer, L. R. et al. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol. Dis. 19, 293â300 (2005).
Wang, M. S. et al. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann. Neurol. 50, 773â779 (2001).
Wang, J. T., Medress, Z. A., Vargas, M. E. & Barres, B. A. Local axonal protection by WldS as revealed by conditional regulation of protein stability. Proc. Natl Acad. Sci. USA 112, 10093â10100 (2015).
Henderson, B. R. & Eleftheriou, A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell. Res. 256, 213â224 (2000).
Cao, C. et al. Discovery of SK-575 as a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for treating cancers. J. Med. Chem. 63, 11012â11033 (2020).
Zhou, G.-C. et al. Design, synthesis and evaluation of a cellular stable and detectable biotinylated fumagillin probe and investigation of cell permeability of fumagillin and its analogs to endothelial and cancer cells. Eur. J. Med. Chem. 70, 631â639 (2013).
Hughes, R. O. et al. Small molecule SARM1 inhibitors recapitulate the SARM1â/â phenotype and allow recovery of a metastable pool of axons fated to degenerate. Cell Rep. 34, 108588 (2021).
Feldman, H. C. et al. Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain. Proc. Natl Acad. Sci. USA 119, e2208457119 (2022).
Sakuma, T., Nakade, S., Sakane, Y., Suzuki, K.-I. T. & Yamamoto, T. MMEJ-assisted gene knock-in using TALENs and CRISPRâCas9 with the PITCh systems. Nat. Protoc. 11, 118â133 (2016).
Sasaki, Y., Vohra, B. P. S., Lund, F. E. & Milbrandt, J. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J. Neurosci. 29, 5525â5535 (2009).
Gerdts, J., Sasaki, Y., Vohra, B., Marasa, J. & Milbrandt, J. Image-based screening identifies novel roles for IκB kinase and glycogen synthase kinase 3 in axonal degeneration. J. Biol. Chem. 286, 28011â28018 (2011).
